Published Paper Details:

Respiratory tract infections (RTIs) are a target of public health development due to their widespread prevalence, irritability, and reported variations worldwide. Clinical findings range from asymptomatic or mild to morbidity or death. Diagnosis must be made quickly to ensure patient satisfaction and take prompt action. Current methods for RTI studies in clinical trials rely on a variety of techniques, including traditional gold standard methods (of which ancient cultures are often used) and the refractive process (e.g., molecular approach), which is often used to understand diseases and disorders. Although this test needs to be used appropriately in different patients, the use of molecular methods from the syndromic process has the potential to be a powerful decision-maker in the management of the patient examination. They radically shorten the time to results and increase the detection of diseases associated with conventional medicine. Additionally, team collaboration, when applied with discretion and careful interpretation, can improve antibiotic use and patient outcomes and improve laboratory work performance. This review provides an overview of the main etiological, clinical and epidemiological aspects of RTI, focusing on clinical diagnosis and the potential of syndromic groups.